MEDX Xelerator Approves New “X Lab” Project to Improve Treatment of Peripheral Venous Disease Care, Forms VeinWay Under CEO Jordan Pollack: Peripheral Device Genius

VeinWay Receives Grant from The Ideation (Tnufa) Incentive Program of The Israel Innovation Authority for $35K

MEDX Xelerator, is an Israel-based medical device and digital health incubator who recently announced the approval of its latest “X Lab” project focused on treating peripheral venous disease (PVD). The newly formed company, VeinWay, will be headed by experienced biomedical engineer and freshman entrepreneur Jordan Pollack.

MEDX Xelerator notes VeinWay recently received a grant of over $35K from The Ideation (Tnufa) Incentive Program of The Israel Innovation Authority. The goal of the grant is to support the company in reaching proof of concept and business feasibility.

MEDX Xelerator’s X Lab program was established to cultivate promising innovation at its earliest stage, supporting and helping inventors and entrepreneurs cultivate their ideas addressing complex unmet clinical needs. By providing resources, industry expertise, and wide-spread networking capabilities, MEDX supports its X Lab entrepreneurs in developing a proof-of-concept, and then, if a proof of concept is demonstrated, advancing these early-stage startups to enter the formal incubator program.

“It’s a great privilege to be inducted into the X Lab program and gain the full support and guidance of the extended MEDX team,” said Jordan Pollack, X Lab Entrepreneur in Residence and CEO of VeinWay. “I am excited to collaborate with MEDX’s experienced and well-connected leadership to leverage my peripheral vasculature expertise and together, to provide the industry with much-needed innovation to improve care for patients with PVD.”

Pollack has spent his career building his engineering experience within the medical device field, having held multiple positions in established, globally traded companies including Boston Scientific and InspireMD. Pollack was also the President and CEO of his own startup, LiveSAVR Solutions, which developed a novel smart guidewire for accurate placement of transcatheter aortic valves. Pollack holds master’s and bachelor’s degrees in biomedical engineering from the University of Michigan.

“Our relationship with Jordan stems back to a joint project with Boston Scientific, where we first noticed his extensive knowledge of the peripheral venous industry and entrepreneurial spirit,” said Shai Policker, CEO of MEDX Xelerator. “Following his recent immigration to Israel, we are delighted to play a role in guiding and nurturing his growth and development within this field, and are happy to assist in Jordan’s goal of elevating the standard of care for PVD management.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy